Greg Lucier joined our board of directors in July 2020 and was named board chair in May 2021. He also serves as a director on the boards of Dentsply Sirona and Maravai LifeSciences. Mr. Lucier has over 25 years of experience in developing and growing innovation-driven companies into market leaders, with expertise in contemporary corporate governance matters and executive management. He currently serves as Chief Executive Officer of Corza Health, Inc., a company focused on acquiring companies and assets as part of a strategy to build a market-leading healthcare business. From 2015 to 2018, he served as Chief Executive Officer of NuVasive, Inc. Mr. Lucier also served as chairperson and Chief Executive Officer at Life Technologies Corporation (formerly Invitrogen Corporation) from May 2003 until it was acquired by Thermo Fisher Scientific Inc. in February 2014. He previously served as a Director on the boards of Life Technologies Corporation (from May 2003 to February 2014), Carefusion Corporation (from August 2009 until its sale to Becton Dickinson in March 2015), Invuity, Inc. (from October 2014 until its sale to Stryker in October 2018), and of Nuvasive (from December 2013 to May 2021). Mr. Lucier received an M.B.A. from Harvard Business School and a B.S. in industrial engineering from Pennsylvania State University.